Jyong Biotech Ltd. (MENS) stock
MENSNasdaqPharmaceutical Preparations
$1.86+0.06 (+3.33%)
Close on Nov 18, 2026Market cap $141.41MP/E –Yield –
Jyong Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$2.51M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.51M | – |
| FY2024 | Dec 31, 2024 | -$1.94M | – |
| FY2023 | Dec 31, 2023 | -$2.67M | – |
See a number that looks wrong?